SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lyka Labs - Quaterly Results

12 Nov 2024 Evaluate
The turnover is pegged at Rs. 411.55 millions for the September 2024 quarter. The mentioned figure indicates a rise of about 53.79% as against Rs. 267.60 millions during the year-ago period.The Total Profit for the quarter ended September 2024 of Rs. 24.74 millions grew from Rs.-2.92 millionsOperating Profit saw a handsome growth to 54.69 millions from 42.40 millions in the quarter ended September 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 411.55 267.60 53.79 712.60 479.97 48.47 1063.96 805.93 32.02
Other Income 1.29 3.04 -57.57 7.49 7.32 2.32 16.47 34.52 -52.29
PBIDT 54.69 42.40 28.99 101.43 72.25 40.39 162.07 190.52 -14.93
Interest 5.17 11.71 -55.85 11.68 25.04 -53.35 47.98 115.70 -58.53
PBDT 49.52 30.24 63.76 89.75 46.76 91.94 113.54 3.08 3586.36
Depreciation 16.83 34.63 -51.40 33.60 67.98 -50.57 122.87 135.16 -9.09
PBT 32.69 -4.39 -844.65 56.15 -21.22 -364.61 -9.33 -132.08 -92.94
TAX 7.95 -1.47 -640.82 13.91 -1.10 -1364.55 13.37 0.78 1614.10
Deferred Tax -0.49 -2.47 -80.16 1.47 -4.45 -133.03 -2.63 -1.29 103.88
PAT 24.74 -2.92 -947.26 42.24 -20.12 -309.94 -22.70 -132.86 -82.91
Equity 356.90 330.90 7.86 356.90 330.90 7.86 330.90 306.90 7.82
PBIDTM(%) 13.29 15.84 -16.13 14.23 15.05 -5.44 15.23 23.64 -35.56

Lyka Labs Share Price

58.16 0.56 (0.97%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×